SEROQUEL

LOE Approaching

quetiapine

NDAORALTABLET
Approved
Sep 1997
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
20

Clinical Trials (5)

NCT04521478Phase 2Completed

A Study to Test the Effect of Different Doses of BI 1358894 and Quetiapine in People With Depression

Started Nov 2020
389 enrolled
Depressive Disorder, Major
NCT04513912Phase 3Completed

A Study of Seltorexant Compared to Quetiapine XR as Adjunctive Therapy to Antidepressants in Adult and Elderly Participants With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant Therapy

Started Sep 2020
757 enrolled
Depressive Disorder, Major
NCT04338321Phase 3Completed

A Long-term Comparison of Esketamine Nasal Spray Versus Quetiapine Extended Release, Both in Combination With a Selective Serotonin Reuptake Inhibitor/Serotonin-Norepinephrine Reuptake Inhibitor, in Participants With Treatment Resistant Major Depressive Disorder

Started Aug 2020
676 enrolled
Depressive Disorder, Major
NCT04164758Phase 2Terminated

Study to Evaluate Safety and Daytime Sedation in Subjects With Parkinson's Disease With Neuropsychiatric Symptoms Treated With Pimavanserin or Low-Dose Quetiapine

Started Oct 2019
11 enrolled
Parkinson's Disease
NCT03872596Phase 1Completed

Trial to Assess the Bioavailability of Quetiapine Versus Seroquel® in Subjects With Schizophrenia or Bipolar Disorder

Started Mar 2019
58 enrolled
Bipolar DisorderSchizophrenia